Analytical Data
-
Gene name
C4orf49
- Application
-
Alternative Names
Protein MGARP. Corneal endothelium-specific Protein 1. CESP-1. Hypoxia up-regulated mitochondrial movement regulator Protein
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8TDB4
-
Expression Region
1-240aa
-
AA Sequence
MYLRRAVSKTLALPLRAPPNPAPLGKDASLRRMSSNRFPGSSGSNMIYYLVVGVTVSAGGYYAYKTVTSDQAKHTEHKTNLKEKTKAEIHPFQGEKENVAETEKASSEAPEELIVEAEVVDAEESPSATVVVIKEASACPGHVEAAPETTAVSAETGPEVTDAAARETTEVNPETTPEVTNAALDEAVTIDNDKDTTKNETSDEYAELEEENSPAESESSAGDDLQEEASVGSEAASAQG
-
Molecular Weight
52.8 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C4orf49, a gene located on chromosome 4, has garnered attention in recent years due to its potential role in various cellular processes, including cell proliferation and apoptosis. Initial studies have suggested that C4orf49 may be involved in the regulation of immune responses and may play a role in certain diseases, including cancer. The protein encoded by this gene is believed to be expressed in several tissues, particularly in the testis and immune cells. However, its precise function and molecular mechanisms remain largely unexplored. To advance our understanding of C4orf49, researchers have turned to recombinant protein technology, allowing for the production of the C4orf49 protein in a controlled laboratory environment. This approach facilitates detailed biochemical characterization, functional assays, and potential therapeutic applications. By investigating the properties and interactions of the C4orf49 recombinant protein, scientists aim to elucidate its biological significance and its potential implications in health and disease. Overall, the study of C4orf49 and its recombinant protein is crucial for uncovering novel pathways in cellular biology and for identifying new targets for therapeutic intervention in diseases where this gene may have a pivotal role.
